Fundraising FoxLigand Pharmaceuticals — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Agenus is a biotechnology company developing cancer immunotherapies, including its lead investigational combination of botensilimab (an anti-CTLA-4 antibody) and balstilimab (a PD-1 inhibitor), known as BOT+BAL.
BiotechHealthtechLexington, US
Garo Armen(Chairman & CEO, Co-founder)Ozer Baysal(Executive Officer)Robert Stein(Executive Officer)Christine Klaskin(Executive Officer)inKaren Valentine(Executive Officer)Steven O'Day(Chief Medical Officer)in
Co-investorsAdvent Life SciencesGrazia Equity GmbHHEALTHCARE ROYALTY PARTNERSOberland CapitalCommodore CapitalInvus+1 more
Zerion is a self-custodial, multichain wallet and data platform that aggregates assets and positions across 58+ blockchains in real time, offering swap routing, trading, and an API for wallet data access.
Crypto & Web3Data & InfrastructureFintechSan Francisco, US
Evgeny Yurtaev(Founder & CEO)inAlex Bashlykov(Director)in
BoardToby Coppel(Director)inVadim Koleoshkin(Director)inBrad Burnham(Director)in
Co-investorsAlliance DAO (ex DeFi Alliance)BitDAOBlockchain CoinvestorsDe Fi Alliance HoldingsDigital Currency GroupG1 Ventures+18 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.